Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis

Isabel Mortimer; Lesley-Anne Bissell; Elizabeth M A Hensor; Lukasz Kozera; Sarah L Mackie; Agata N Burska; Jackie L Nam; Helen Keen; Edith Villeneuve; Helena Donica; Maya H Buch; Philip G Conaghan; Paul Emery; Ann W Morgan; Jacqueline Andrews

doi:10.1093/rheumatology/kez114

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis

Isabel Mortimer, Lesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, Sarah L Mackie, Agata N Burska, Jackie L Nam, Helen Keen, Edith Villeneuve, Helena Donica, Maya H Buch, Philip G Conaghan, Paul Emery, Ann W Morgan, Jacqueline Andrews

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1684-1686
Number of pages	3
Journal	Rheumatology (Oxford, England)
Volume	58
Issue number	9
DOIs	https://doi.org/10.1093/rheumatology/kez114
Publication status	Published - 1 Sept 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/rheumatology/kez114

Cite this

Mortimer, I., Bissell, L.-A., Hensor, E. M. A., Kozera, L., Mackie, S. L., Burska, A. N., Nam, J. L., Keen, H., Villeneuve, E., Donica, H., Buch, M. H., Conaghan, P. G., Emery, P., Morgan, A. W., & Andrews, J. (2019). Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis. Rheumatology (Oxford, England), 58(9), 1684-1686. https://doi.org/10.1093/rheumatology/kez114

@article{90d997b63a0f404e8c29022104f8fe5c,

title = "Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis",

author = "Isabel Mortimer and Lesley-Anne Bissell and Hensor, {Elizabeth M A} and Lukasz Kozera and Mackie, {Sarah L} and Burska, {Agata N} and Nam, {Jackie L} and Helen Keen and Edith Villeneuve and Helena Donica and Buch, {Maya H} and Conaghan, {Philip G} and Paul Emery and Morgan, {Ann W} and Jacqueline Andrews",

year = "2019",

month = sep,

day = "1",

doi = "10.1093/rheumatology/kez114",

language = "English",

volume = "58",

pages = "1684--1686",

journal = "Rheumatology (Oxford, England)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "9",

}

Mortimer, I, Bissell, L-A, Hensor, EMA, Kozera, L, Mackie, SL, Burska, AN, Nam, JL, Keen, H, Villeneuve, E, Donica, H, Buch, MH, Conaghan, PG, Emery, P, Morgan, AW & Andrews, J 2019, 'Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis', Rheumatology (Oxford, England), vol. 58, no. 9, pp. 1684-1686. https://doi.org/10.1093/rheumatology/kez114

TY - JOUR

T1 - Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis

AU - Mortimer, Isabel

AU - Bissell, Lesley-Anne

AU - Hensor, Elizabeth M A

AU - Kozera, Lukasz

AU - Mackie, Sarah L

AU - Burska, Agata N

AU - Nam, Jackie L

AU - Keen, Helen

AU - Villeneuve, Edith

AU - Donica, Helena

AU - Buch, Maya H

AU - Conaghan, Philip G

AU - Emery, Paul

AU - Morgan, Ann W

AU - Andrews, Jacqueline

PY - 2019/9/1

Y1 - 2019/9/1

U2 - 10.1093/rheumatology/kez114

DO - 10.1093/rheumatology/kez114

M3 - Letter

C2 - 31329965

SN - 1462-0324

VL - 58

SP - 1684

EP - 1686

JO - Rheumatology (Oxford, England)

JF - Rheumatology (Oxford, England)

IS - 9

ER -